Cargando…

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Detalles Bibliográficos
Autor principal:	Bendjelid, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347253/ https://www.ncbi.nlm.nih.gov/pubmed/32646518 http://dx.doi.org/10.1186/s13054-020-03144-6

Ejemplares similares

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report
por: Šribar, Andrej, et al.
Publicado: (2023)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series
por: Konkol, Samuel B., et al.
Publicado: (2022)

Vasopressin in vasoplegic shock: A systematic review
por: Webb, Andrew J, et al.
Publicado: (2020)

No coronary artery occlusion in septic shock: Isoproterenol infusion should not be discouraged
por: Leone, Marc, et al.
Publicado: (2015)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist undergoing coronary artery bypass graft surgery: a randomized controlled study
por: Saleh, Mohamed, et al.
Publicado: (2020)

Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock
por: Ranzani, Otavio Tavares, et al.
Publicado: (2013)

Vasopressin in vasoplegic shock in surgical patients: systematic review and meta-analysis
por: Szeles, Taís Felix, et al.
Publicado: (2023)

Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature
por: Maier, Alexander, et al.
Publicado: (2019)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

The Efficacy of Albumin Dialysis in the Reversal of Refractory Vasoplegic Shock Due to Amlodipine Toxicity
por: Connor-Schuler, Randi L., et al.
Publicado: (2020)

Stratifying septic patients using lactate: severe sepsis and cryptic, vasoplegic and dysoxic shock profile
por: Ranzani, Otavio T, et al.
Publicado: (2013)

Comment on “Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options”
por: Ortoleva, Jamel, et al.
Publicado: (2020)

Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)

Should ECMO be used in cardiogenic shock?
por: Gokalp, Orhan, et al.
Publicado: (2019)

Vasopressor-Refractory Shock From Clozapine Overdose Treated With Synthetic Angiotensin II Infusion
por: Wieruszewski, Patrick M., et al.
Publicado: (2020)

COVID-19: desperate times call for desperate measures
por: von Düring, Stephan, et al.
Publicado: (2020)

Isoproterenol infusion in septic shock
por: Wiwanitkit, Viroj
Publicado: (2015)

Intradialytic hypotension and cardiac remodeling: should we consider the renin-angiotensin-aldosterone system?
por: Wang, Juanli, et al.
Publicado: (2021)

The use of angiotensin II in distributive shock
por: Chawla, Lakhmir S., et al.
Publicado: (2016)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

COVID-19: should we continue to cryopreserve sperm during the pandemic?
por: Yakass, Michael Bright, et al.
Publicado: (2020)

Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
por: Serpa Neto, Ary, et al.
Publicado: (2022)

Treatment with angiotensin II in COVID-19 patients may not be beneficial
por: Rysz, Susanne, et al.
Publicado: (2020)

Angiotensin in ECMO patients with refractory shock
por: Ostermann, Marlies, et al.
Publicado: (2018)

CPR in COVID-19: Should We Use the PAPR to Keep the Savior Safe?
por: Saran, Sai
Publicado: (2021)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Norepinephrine infusion in septic shock
por: Haranath, P. S. R. K.
Publicado: (2008)

The meaning of the Low Optimum End-Expiratory Airway Pressure value found in some COVID-19 patients
por: Bendjelid, Karim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a3dnnc530cqc5tfo1ehtdovgpi